Gastroenterology Portfolio
Inflammatory Bowel Disease (IBD), Colonic Infections, Colorectal Cancer (CRC)
Not SpecifiedActive
Key Facts
Indication
Inflammatory Bowel Disease (IBD), Colonic Infections, Colorectal Cancer (CRC)
Phase
Not Specified
Status
Active
Company
About Cosmo
Cosmo is a diversified life sciences company leveraging AI and digital health to advance therapeutics and technologies in dermatology, gastroenterology, and medical AI. With a business model encompassing proprietary drug development and contract manufacturing services, it targets significant unmet needs in gut and skin health. The company appears to be in a commercial stage, given its CDMO operations and focus on bringing therapies to market through partnerships.
View full company profile